Literature DB >> 9548594

Modification of a phospholipid stabilized emulsion interface by bile salt: effect on pancreatic lipase activity.

M Wickham1, M Garrood, J Leney, P D Wilson, A Fillery-Travis.   

Abstract

Lipase is activated by binding to an insoluble emulsified or aggregated substrate. The extent of binding is related to the physicochemical as well as the compositional structure of the interface, the quality of the interface. 'Quality' is as yet undefined but thought to contain contributions from electrostatic interactions, orientation of substrate, and hydration forces. To investigate the electrostatic and compositional factors we have used olive oil-in-water emulsions prepared with phosphatidylcholine and four bile salts of varying hydrophobicities. By measurement of the droplet zeta potential we have monitored semi-quantitatively the incorporation of bile salts within the interface. No correlation was found between droplet surface charge as monitored by the zeta potential and lag phase. The duration of the observed lag phase was found to be inversely related to the degree of incorporation of the bile salts. Simultaneously there was evidence of lipase binding to monomeric bile salts, reducing its availability for adsorption. Calcium ions reduced the surface charge but there was no correlation with lag phase duration. The evidence presented here agrees with a more specific role for calcium ions, i.e., the formation of a new catalytically active enzyme complex, (enzyme)-(mixed micelle)-(calcium ion).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548594

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  10 in total

1.  Colloidal structures in media simulating intestinal fed state conditions with and without lipolysis products.

Authors:  Dimitrios G Fatouros; Isabelle Walrand; Bjorn Bergenstahl; Anette Müllertz
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

2.  Influence of Surfactants on Lipase Fat Digestion in a Model Gastro-intestinal System.

Authors:  Pedro M Reis; Thomas W Raab; Jean Y Chuat; Martin E Leser; Reinhard Miller; Heribert J Watzke; Krister Holmberg
Journal:  Food Biophys       Date:  2008-06-26       Impact factor: 3.114

Review 3.  Pharmacology of bile acids and their derivatives: absorption promoters and therapeutic agents.

Authors:  M Mikov; J P Fawcett; K Kuhajda; S Kevresan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

4.  Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.

Authors:  Stephanie Bosselmann; Masao Nagao; Keat T Chow; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2012-06-30       Impact factor: 3.246

5.  Absorption properties of micellar lipid metabolites into Caco2 cells.

Authors:  Wakako Tsuzuki
Journal:  Lipids       Date:  2007-06-21       Impact factor: 1.880

Review 6.  Characterising lipid lipolysis and its implication in lipid-based formulation development.

Authors:  Nicky Thomas; René Holm; Thomas Rades; Anette Müllertz
Journal:  AAPS J       Date:  2012-09-07       Impact factor: 4.009

7.  Porous Silica-Supported Solid Lipid Particles for Enhanced Solubilization of Poorly Soluble Drugs.

Authors:  Rokhsana Yasmin; Shasha Rao; Kristen E Bremmell; Clive A Prestidge
Journal:  AAPS J       Date:  2016-04-05       Impact factor: 4.009

8.  Preparation and characterization of nanoemulsions of curcumin and echium oil.

Authors:  Aslı Inal; Hande Yenipazar; Neşe Şahin-Yeşilçubuk
Journal:  Heliyon       Date:  2022-02-16

9.  Porcine bile acids promote the utilization of fat and vitamin A under low-fat diets.

Authors:  Bowen Yang; Shimeng Huang; Ning Yang; Aizhi Cao; Lihong Zhao; Jianyun Zhang; Guoxian Zhao; Qiugang Ma
Journal:  Front Nutr       Date:  2022-09-28

Review 10.  Phospholipids at the interface: current trends and challenges.

Authors:  Roman Pichot; Richard L Watson; Ian T Norton
Journal:  Int J Mol Sci       Date:  2013-06-03       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.